Clinical Utility of Enzyme-Linked Immunosorbent Assay for Hepatitis C Core Antigen Quantification in Diagnosis and Monitoring Patients Treated with Direct-Acting Antivirals in A R - Egyptian Knowledge Bank

112402

Clinical Utility of Enzyme-Linked Immunosorbent Assay for Hepatitis C Core Antigen Quantification in Diagnosis and Monitoring Patients Treated with Direct-Acting Antivirals in A R

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

Correlation between Serum Levels of HCV Core Antigen and Liver Enzymes for Assessment of Disease Activity in Chronic Hepatitis C Patients

Article

Evaluation of some available HCV antibody detection tests (ELISA, Chemiluminescence, Immune Assay) and RT-PCR assay in the diagnosis of Hepatitis C virus infection

Article

Prospective Study of Changes in Anti-HCV Immunoglobulin G Antibody Titers after Treatment with Direct Acting Antiviral Agents

Article

Quantitative and Qualitative Evaluation of Hepatitis C Virus Core Antigen (HCVcAg) as an Alternative Diagnostic Marker in Chronic HCV Infection

Article

HEPATITIS C VIRUS (HCV) CORE ANTIGEN AS AN ALTERNATIVE TO PCR FOR HCV, RNA QUANTIFICATION TO EARLY DIAGNOSIS OF HCV INFECTION AMONG BLOOD DONORS

Article

Assessment of Degree of Fibrosis in Chronic Hepatitis C Virus Patients Treated with Direct Acting Antiviral Agents

Article

EVALUATION OF REAL-TIME RT-PCR QUANTITATION OF HCV RNA COMPARED TO OTHER DIAGNOSTIC METHODS

Article

Isolation of Hepatitis C Virus Antigen El and Establishment of a Comparison of its Level in Different Fibrosis Stages in Patients Infected with Chronic Hepatitis C

Article

Value of HCV Core Antigen Testing in Detection of HCV Antibody Negative HCV Infection in Patients with Asymptomatic Elevation of Liver Transaminases of Unknown Etiology

Article

Pretreatment serum alpha fetoprotein and its relation to sustained virologic response in patients with chronic HCV infection treated with direct-acting antiviral therapy